Martha Reilley
Nurse Practitioner · Annapolis, MDNPI 1003381997
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 802 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 802 payments — averaging $22.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Harmony Biosciences LLC$2K
- Insmed, Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- plus $9K from 34 others
What the payments were for
- Food & beverage$17,54198%
- Education$4212%
- Entertainment$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,979 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 145 | $184,569 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 75 | $62,707 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 48 | $40,899 |
| Spiriva RespimatTiotropium Bromide | 36 | $32,162 |
| Breo ElliptaFluticasone/Vilanterol | 47 | $31,136 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $3,580 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 129 | $3,574 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 14 | $2,851 |
| Wixela InhubFluticasone Propion/Salmeterol | 16 | $2,650 |
| Azelastine Hcl | 46 | $1,634 |
| Azithromycin | 52 | $1,440 |
| Ventolin HfaAlbuterol Sulfate | 17 | $976 |
| Montelukast Sodium | 23 | $681 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $511 |
| Fluticasone Propionate | 30 | $437 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $1,811 | $256,603240 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $2,426 | $66,28787 claims |
| Boehringer IngelheimSpiriva Respimat | $717 | $32,16236 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Other nurse practitioner in Annapolis
- Stephanie ZwonitzerAnnapolis$16K
- Diane SchmidtAnnapolis$9K
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Jennifer MaglianoTimonium$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.